Correlation between Diabetes Mellitus and vision loss, the long-term effects of the conjunction, & how treating one may help or impair the other: A Review

Authors

  • Ray R Assistant Professor Haldia Institute of Management

Keywords:

Complications, diabetes

Abstract

Diabetes and related complications are associated with long-term damage and failure of various organ systems. The line of demarcation between the pathogenic mechanisms of microvascular and macrovascular complications of diabetes and differing responses to therapeutic interventions is blurred. Diabetes induces changes in the microvasculature, causing extracellular matrix protein synthesis, and capillary basement membrane thickening which are the pathognomy features of diabetic microangiopathy. These changes in conjunction with advanced glycation end products, oxidative stress, low grade inflammation, and neovascularization of vasa vasorum can lead to macrovascular complications. Hyperglycaemia is the principal cause of micro vasculopathy but also appears to play an important role in causation of macro vasculopathy. There is thought to be an intersection between micro and macro vascular complications, but the two disorders seem to be strongly interconnected, with micro vascular diseases promoting atherosclerosis through processes such as hypoxia and changes in vasa vasorum. It is thus imperative to understand whether microvascular complications distinctly precede macrovascular complications or do both of them progress simultaneously as a continuum. This will allow re-focusing on the clinical issues with a unifying perspective which can improve type 2 diabetes mellitus outcomes.

References

Balaji, R., Duraisamy, R., & Santhosh Kumar, M. P. (2019). Complications of diabetes mellitus: A review. Drug Invention Today, 12(1), 98–103.

Cecilia, O. M., Jose Alberto, C. G., Jose, N. P., Ernesto German, C. M., Ana Karen, L. C., Luis Miguel, R. P., Ricardo Raul, R. R., & Adolfo Daniel, R. C. (2019). Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology. Journal of Diabetes Research, 2019. https://doi.org/10.1155/2019/8562408

Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A. PROactive Study Group. The prospective pioglitazone clinical trial in macrovascular events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care. 2004;27:1647–53.

Chawla A, Chawla R, Bhasin GK, Soota K. Profile of adolescent diabetics in North Indian population. J Clin Diabetol. 2014;1:1–3.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.

Howells, L. H. (1953). Ocular complications of diabetes mellitus. British Journal of Ophthalmology, 37(12), 716–724. https://doi.org/10.1136/bjo.37.12.716

International Diabetes Federation. IDF Atlas. 7th edition. [Last accessed on 2015 Dec 27].

Downloads

Published

2018-03-30

How to Cite

Ray, R. (2018). Correlation between Diabetes Mellitus and vision loss, the long-term effects of the conjunction, & how treating one may help or impair the other: A Review. Innovative Research Thoughts, 4(4), 345–353. Retrieved from https://irt.shodhsagar.com/index.php/j/article/view/846